Drug Safety Architects
Our purpose is to empower biotech innovators by simplifying the complexities of drug safety, enabling them to bring groundbreaking therapies to market efficiently and with full regulatory compliance.
Our vision
Our vision is to transform drug safety from basic regulatory compliance to value generation.
A trusted advisor in pursuit of your growth.
Helping biotechs and innovators bring drugs to market.
Strategic advice built to support innovation.
Our mission is help biotech companies navigate drug safety regulations. We demystify pharmacovigilance, partnering with biotech companies in their growth phase from clinical trials into post-marketing, providing drug safety advice built on deep industry experience.
Understanding and globalising PV is hard. We simplify the complex.
Our values
Integrity
Prioritizing patient safety and trustworthiness.
Excellence
Leveraging deep-rooted expertise for continuous improvement
Agility
Being nimble and agile to adapt to our client's needs.
Empowerment
Equipping our clients with the autonomy to excel.
Sectors we serve
Small & Emerging Biotech
Early to mid-stage biotech companies, usually focusing on research, discovery, and early-phase clinical trials (Phase I and Phase II).
Late Stage Biotech
Companies in the later stages of clinical trials (typically Phase III) and those nearing or at the stage of regulatory submission and commercialization.
Established Biotech
Mature biotech with successful commercial products. Marketed drugs, advanced R&D.
Big Pharma
Large multinational companies with broad portfolios. Marketed drugs & extensive pipelines.
Generic Pharma
Companies producing & marketing generic versions of drugs after patent expiry. Post-patent & low R&D.
Specialty Pharma
Companies with a focus on niche therapeutic areas or specific patient needs, with late-stage & niche drugs.